SELARL PHARMACIE AGEL

SELARL PHARMACIE AGEL

SIREN 877970624

Active

What the register says about SELARL PHARMACIE AGEL

SELARL PHARMACIE AGEL is registered under SIREN number 877970624. Its registered office is located at 17-19 rue Maurice Segonds - Centre commercial Agel, 60000 Beauvais. The company was founded on 23/09/2019. It declares that it operates in the Commerce de détail de produits pharmaceutiques en magasin spécialisé sector. It is currently listed as active in the national business register.

BODACC has published 10 notices concerning it, the most recent dated 28/06/2026. An account filing makes public the annual accounts submitted to the court registry: it confirms that accounting records exist and have been filed, nothing more. It says nothing about revenue, profit, or the commercial health of the company. A modification signals a declared change: management, registered office, activity, or share capital.

Identity : SELARL PHARMACIE AGEL

SELARL PHARMACIE AGEL

SIREN
877970624
Head office SIRET
87797062400020
Legal form
5485
NAF code
47.73Z · Commerce de détail de produits pharmaceutiques en magasin spécialisé
Address
17-19 rue Maurice Segonds - Centre commercial Agel, 60000 Beauvais
Creation date
09/23/2019
Category
PME
Status
Active
VAT
FR74877970624
Filing
06/28/2026
Closing
09/30/2025

Recent notices (10)

All legal notices

Web presence : SELARL PHARMACIE AGEL

The company's official website, its networks and online contact details.

Recent notices : SELARL PHARMACIE AGEL

The BODACC notices published for this company.

Relations : SELARL PHARMACIE AGEL

The relationship graph: linked notices, people and companies.

Public contracts : SELARL PHARMACIE AGEL

The public contracts won by the company.

No won public contract found for this company

FAQ & filings : SELARL PHARMACIE AGEL

Frequently asked questions and the company's filing history.

Frequently asked questions : SELARL PHARMACIE AGEL

Deposit filing history

6 dépôts de comptes enregistrés au BODACC — dernier exercice clos le 09/30/2025.